The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Bart Staels

Inserm UR 1011

Institut Pasteur de Lille

1 rue du Professeur Calmette

BP 245

France.

[email]@pasteur-lille.fr

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Inserm UR 1011, Institut Pasteur de Lille, 1 rue du Professeur Calmette, BP 245, France.. 1998 - 2012
  • Corresponding author: Bart Staels. 2011
  • Institut Pasteur, Lille, France. 2007 - 2009
  • Universite Lille Nord de France, Inserm U545, UDSL, Lille, France. 2009
  • Institut Pasteur de Lille, INSERM U545, Université Lille Nord de France, Lille, France. 2009
  • Department of Atherosclerosis, Institut Pasteur de Lille, UMR545 Inserm, University of Lille 2, France. 2000 - 2008
  • Department of Atherosclerosis, Unité INSERM 545-Institut Pasteur, 1, rue du Professeur Calmette, 59019 Lille Cedex, France. 2005

References

  1. Impaired alternative macrophage differentiation of peripheral blood mononuclear cells from obese subjects. Bories, G., Caiazzo, R., Derudas, B., Copin, C., Raverdy, V., Pigeyre, M., Pattou, F., Staels, B., Chinetti-Gbaguidi, G. Diab. Vasc. Dis. Res (2012) [Pubmed]
  2. Peroxisome Proliferator-Activated Receptor-γ Activation Induces 11β-Hydroxysteroid Dehydrogenase Type 1 Activity in Human Alternative Macrophages. Chinetti-Gbaguidi, G., Bouhlel, M.A., Copin, C., Duhem, C., Derudas, B., Neve, B., Noel, B., Eeckhoute, J., Lefebvre, P., Seckl, J.R., Staels, B. Arterioscler. Thromb. Vasc. Biol. (2012) [Pubmed]
  3. Farnesoid x receptor deficiency improves glucose homeostasis in mouse models of obesity. Prawitt, J., Abdelkarim, M., Stroeve, J.H., Popescu, I., Duez, H., Velagapudi, V.R., Dumont, J., Bouchaert, E., van Dijk, T.H., Lucas, A., Dorchies, E., Daoudi, M., Lestavel, S., Gonzalez, F.J., Oresic, M., Cariou, B., Kuipers, F., Caron, S., Staels, B. Diabetes (2011) [Pubmed]
  4. Human Atherosclerotic Plaque Alternative Macrophages Display Low Cholesterol Handling but High Phagocytosis Because of Distinct Activities of the PPAR{gamma} and LXR{alpha} Pathways. Chinetti-Gbaguidi, G., Baron, M., Bouhlel, M.A., Vanhoutte, J., Copin, C., Sebti, Y., Derudas, B., Mayi, T., Bories, G., Tailleux, A., Haulon, S., Zawadzki, C., Jude, B., Staels, B. Circ. Res. (2011) [Pubmed]
  5. Bile acid sequestrants for lipid and glucose control. Staels, B., Handelsman, Y., Fonseca, V. Curr. Diab. Rep. (2010) [Pubmed]
  6. Efficacy of peroxisome proliferator-activated receptor agonists in diabetes and coronary artery disease. Fiévet, C., Staels, B. Curr. Atheroscler. Rep (2009) [Pubmed]
  7. A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus. Staels, B. Postgrad. Med (2009) [Pubmed]
  8. Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration. Staels, B., Fonseca, V.A. Diabetes. Care (2009) [Pubmed]
  9. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease. Staels, B., Maes, M., Zambon, A. Nat. Clin. Pract. Cardiovasc. Med (2008) [Pubmed]
  10. Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Staels, B., Kuipers, F. Drugs (2007) [Pubmed]
  11. PPAR agonists and the metabolic syndrome. Staels, B. Therapie (2007) [Pubmed]
  12. Metformin and pioglitazone: Effectively treating insulin resistance. Staels, B. Curr. Med. Res. Opin (2006) [Pubmed]
  13. PPARgamma and atherosclerosis. Staels, B. Curr. Med. Res. Opin (2005) [Pubmed]
  14. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Staels, B., Fruchart, J.C. Diabetes (2005) [Pubmed]
  15. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall. Chinetti, G., Fruchart, J.C., Staels, B. Z. Kardiol (2001) [Pubmed]
  16. Regulation of lipid and lipoprotein metabolism by retinoids. Staels, B. J. Am. Acad. Dermatol. (2001) [Pubmed]
  17. Nuclear transcription factors: new opportunities for lipid lowering. Staels, B. Proc. Nutr. Soc (2000) [Pubmed]
  18. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I.P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.C., Najib, J., Maclouf, J., Tedgui, A. Nature (1998) [Pubmed]
  19. Regulation of apo A-I gene expression by fibrates. Staels, B., Auwerx, J. Atherosclerosis (1998) [Pubmed]
 
WikiGenes - Universities